131 related articles for article (PubMed ID: 29861596)
41. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
Alebic MŠ; Stojanovic N; Dewailly D
Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
[TBL] [Abstract][Full Text] [Related]
42. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
La Marca A; Sunkara SK
Hum Reprod Update; 2014; 20(1):124-40. PubMed ID: 24077980
[TBL] [Abstract][Full Text] [Related]
43. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
[TBL] [Abstract][Full Text] [Related]
44. Anti-Müllerian hormone (AMH) as a good predictor of time of menopause.
Kruszyńska A; Słowińska-Srzednicka J
Prz Menopauzalny; 2017 Jun; 16(2):47-50. PubMed ID: 28721129
[TBL] [Abstract][Full Text] [Related]
45. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
[TBL] [Abstract][Full Text] [Related]
46. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
47. The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure.
Motawi TMK; Rizk SM; Maurice NW; Maged AM; Raslan AN; Sawaf AH
J Assist Reprod Genet; 2017 Dec; 34(12):1659-1666. PubMed ID: 28825151
[TBL] [Abstract][Full Text] [Related]
48. Anti-Müllerian hormone and its role in ovarian function.
Gruijters MJ; Visser JA; Durlinger AL; Themmen AP
Mol Cell Endocrinol; 2003 Dec; 211(1-2):85-90. PubMed ID: 14656480
[TBL] [Abstract][Full Text] [Related]
49. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
[TBL] [Abstract][Full Text] [Related]
50. Anti-Mullerian hormone concentrations in individual follicular fluids within one stimulated IVF cycle resemble blood serum values.
Schenk M; Kröpfl JM; Obermayer-Pietsch B; Feldmeier E; Weiss G
J Assist Reprod Genet; 2017 Sep; 34(9):1115-1120. PubMed ID: 28324271
[TBL] [Abstract][Full Text] [Related]
51. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
[TBL] [Abstract][Full Text] [Related]
52. Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
La Marca A; Volpe A
Clin Endocrinol (Oxf); 2006 Jun; 64(6):603-10. PubMed ID: 16712660
[TBL] [Abstract][Full Text] [Related]
53. Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?
Iwase A; Nakamura T; Osuka S; Takikawa S; Goto M; Kikkawa F
Reprod Med Biol; 2016 Jul; 15(3):127-136. PubMed ID: 29259429
[TBL] [Abstract][Full Text] [Related]
54. Anti-mullerian hormone as a marker of ovarian reserve.
Tremellen KP; Kolo M; Gilmore A; Lekamge DN
Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
[TBL] [Abstract][Full Text] [Related]
55. Anti-Müllerian hormone: a critical factor for female fertility and reproductive health.
Rzeszowska M; Leszcz A; Putowski L; Hałabiś M; Tkaczuk-Włach J; Kotarski J; Polak G
Ginekol Pol; 2016; 87(7):532-7. PubMed ID: 27504948
[TBL] [Abstract][Full Text] [Related]
56. Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure.
Bonilla-Musoles F; Castillo JC; Caballero O; Pérez-Panades J; Bonilla F; Dolz M; Osborne N
Clin Exp Obstet Gynecol; 2012; 39(1):13-8. PubMed ID: 22675946
[TBL] [Abstract][Full Text] [Related]
57. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve.
Romanski PA; Bortoletto P; Rosenwaks Z; Schattman GL
Hum Reprod; 2020 Jul; 35(7):1630-1636. PubMed ID: 32544225
[TBL] [Abstract][Full Text] [Related]
58. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen.
Freour T; Masson D; Dessolle L; Allaoua D; Dejoie T; Mirallie S; Jean M; Barriere P
Arch Gynecol Obstet; 2012 Apr; 285(4):1177-82. PubMed ID: 22183426
[TBL] [Abstract][Full Text] [Related]
59. [Acupuncture combined with medication improves endocrine hormone levels and ovarian reserve function in poor ovarian response patients undergoing in vitro fertilization-embryo transplantation].
Dong XL; Ran JK; Zhang HJ; Chen K; Li HX
Zhen Ci Yan Jiu; 2019 Aug; 44(8):599-604. PubMed ID: 31475495
[TBL] [Abstract][Full Text] [Related]
60. What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?
Knez J; Kovačič B; Medved M; Vlaisavljević V
Reprod Biol Endocrinol; 2015 Jun; 13():58. PubMed ID: 26059906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
